Document Detail


Sturge-Weber syndrome: a review.
MedLine Citation:
PMID:  15165630     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Sturge-Weber syndrome is a rare disorder that occurs with a frequency of approximately 1 per 50,000. The disease is characterized by an intracranial vascular anomaly, leptomeningeal angiomatosis, most often involving the occipital and posterior parietal lobes. Facial cutaneous vascular malformations, seizures, and glaucoma are among the most common symptoms and signs. Stasis results in ischemia underlying the leptomeningeal angiomatosis, leading to calcification and laminar cortical necrosis. The clinical course is highly variable and some children experience intractable seizures, mental retardation, and recurrent strokelike episodes. In this review, we describe the syndrome's characteristic features, clinical course, and optimal management.
Authors:
Kristin A Thomas-Sohl; Dale F Vaslow; Bernard L Maria
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Pediatric neurology     Volume:  30     ISSN:  0887-8994     ISO Abbreviation:  Pediatr. Neurol.     Publication Date:  2004 May 
Date Detail:
Created Date:  2004-05-28     Completed Date:  2004-07-27     Revised Date:  2006-05-23    
Medline Journal Info:
Nlm Unique ID:  8508183     Medline TA:  Pediatr Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  303-10     Citation Subset:  IM    
Affiliation:
Department of Child Health, University of Missouri-Columbia, Missouri, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Epilepsy / complications,  pathology,  therapy
Headache / complications,  pathology,  therapy
Humans
Sturge-Weber Syndrome / complications,  pathology*,  therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Isomers of trans fatty acids modify the activity of platelet 12-P lipoxygenase and cyclooxygenase/th...
Next Document:  Predicting outcome of initial treatment with carbamazepine in childhood focal epilepsy.